首页> 外文期刊>The American heart journal >Evidence of disparity in the application of quality improvement efforts for the treatment of acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice Initiative in Michigan
【24h】

Evidence of disparity in the application of quality improvement efforts for the treatment of acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice Initiative in Michigan

机译:质量改善措施在治疗急性心肌梗塞中的应用差异的证据:美国密歇根州心脏病学会实践实践指南

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Racial disparities exist in the management of patients with cardiovascular disease in the United States. The aim of the study was to evaluate if a structured initiative for improving care of patients with acute myocardial infarction (Guidelines Applied in Practice [GAP]) led to comparable care of white and nonwhite patients admitted to GAP hospitals in Michigan. Methods: Medicare patients comprised 2 cohorts: (1) those admitted before GAP implementation (n = 1,368) and (2) those admitted after GAP implementation (n = 1,489). The main outcome measure was adherence to guideline-based medications/recommendations and use of the GAP discharge tool. χ 2 and Fisher exact tests were used to determine differences between white patients (n = 2,367) and nonwhite patients (n = 490). Results: In-hospital GAP tool and aspirin use significantly improved for white and nonwhite patients. β-Blocker use in hospital improved significantly for nonwhite patients only (66% vs 83.3%; P = .04). At discharge, nonwhite patients were 28% and 64% less likely than white patients to have had the GAP discharge tool used (P = .004) and receive smoking cessation counseling (P .001), respectively. Among white patients, GAP improved discharge prescription rates for aspirin by 10.8% (P .001) and β-blockers by 7.0% (P = .047). Nonwhite patients' aspirin prescriptions increased by 1.0% and β-blocker prescriptions decreased by 6.0% (both P values nonsignificant). Conclusions: The GAP program led to significant increases in rates of evidence-based care in both white and nonwhite Medicare patients. However, nonwhite patients received less quality improvement discharge tool and smoking cessation counseling. Policies designed to reduce racial disparities in health care must address disparity in the delivery of quality improvement programs.
机译:背景:在美国,心血管疾病患者的治疗存在种族差异。这项研究的目的是评估改善急性心肌梗塞患者护理的结构性举措(实践指南[GAP])是否能使密歇根州GAP医院的白人和非白人患者获得可比的护理。方法:Medicare患者包括2个队列:(1)实施GAP之前入院的患者(n = 1,368)和(2)实施GAP之后入院的患者(n = 1,489)。主要结局指标是遵守基于指南的药物/建议以及使用GAP出院工具。 χ2和Fisher精确检验用于确定白人患者(n = 2367)和非白人患者(n = 490)之间的差异。结果:白人和非白人患者的院内GAP工具和阿司匹林的使用显着改善。仅非白人患者在医院中使用β受体阻滞剂有显着改善(66%比83.3%; P = .04)。出院时,非白人患者使用GAP出院工具(P = .004)和接受戒烟咨询的可能性分别比白人患者低28%和64%(P <.001)。在白人患者中,GAP使阿司匹林的出院处方率提高了10.8%(P <.001),β受体阻滞剂提高了7.0%(P = .047)。非白人患者的阿司匹林处方增加1.0%,β受体阻滞剂处方减少6.0%(P值均无统计学意义)。结论:GAP计划导致白人和非白人Medicare患者的循证护理率显着提高。但是,非白人患者接受的质量改善出院工具和戒烟咨询较少。旨在减少医疗保健中种族差异的政策必须解决提供质量改进计划方面的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号